Goodsurance

Drug prices & Part D

Zero-Premium Part D Drug Plans Disappear in 2027, Leaving 4 Million Enrollees Without the Free Option They Had This Year

A KFF analysis published the day plan shopping opened finds no standalone Medicare drug plan will be offered at zero monthly cost to non-subsidized enrollees in 2027, and some face increases of 50 dollars or more per month if they do not switch.

By the Goodsurance editorial teamOctober 2, 2026

A KFF analysis published October 2, 2026, finds that for the first time, no standalone Medicare prescription drug plan will be offered at zero monthly premium to enrollees who do not receive the low-income subsidy. In 2026, about 4 million non-subsidized enrollees, roughly 28 percent of all standalone drug plan members without extra help, paid nothing per month for their coverage. Every one of those enrollees will pay something in 2027.

For most plan holders, the change will be modest. The federal benchmark average monthly premium across standalone plans is projected to rise less than 1 dollar, from 35.09 dollars to 36 dollars. Many enrollees can keep their increase small by actively comparing options and switching to a lower-cost alternative during open enrollment.

Zero-premium Part D plans are gone for 2027. Four million Medicare enrollees need to shop before December 7.

The stakes are higher for those who do not shop. KFF found that for at least one major branded plan, enrollees who keep their current coverage could face monthly increases of 50 dollars or more in all 50 states and Washington D.C. The count of standalone plan options available to the average beneficiary continues to fall, reaching 9 in 2027, down from 11 in 2026, part of a four-year decline.

The annual Medicare open enrollment period begins October 15 and closes December 7, 2026. All plan changes take effect January 1, 2027.

In plain words

In 2027, there will be no Medicare drug plans that cost zero per month for people who do not get extra help paying for Medicare. About 4 million people paid nothing for their drug plan in 2026. All of them will have to pay something next year. If you shop for a cheaper plan, the change may be less than 1 dollar a month. But if you stay in certain plans without comparing, you could pay 50 dollars more each month. There are also fewer plans to pick from. Open enrollment runs October 15 to December 7.

Source: KFF
Read at the source →

More news

Other stories on what is moving in Medicare.

Drug prices & Part D

Medicare Sent Its Final Drug Price Offers by September 30. Manufacturers Now Have Until October 31 to Respond.

With the statutory September 30 written-offer deadline now passed, each manufacturer whose drug is in Medicare's third negotiation cycle must accept or reject CMS's maximum fair price offer in writing by October 31, closing the formal negotiation period.

October 1, 2026

Drug prices & Part D

CMS Finalizes Mandatory Model to Tie Medicare Part B Drug Prices to International Benchmarks

A five-year payment test launching January 1, 2027, will require drug manufacturers to pay rebates when what they charge Medicare exceeds prices paid in 19 other countries, affecting about one quarter of Original Medicare enrollees.

October 1, 2026

Drug prices & Part D

CMS Asks the Public to Help Define Fair Pharmacy Contract Terms for Medicare Drug Plans

A 2026 federal spending law will require Medicare Part D plans to accept any pharmacy that agrees to standard contract terms starting in 2029. A new request for information is the first step toward writing those standards.

September 26, 2026

Drug prices & Part D

OIG Report Finds Medicare Part B Drug Price-Substitution Mechanism Saved 1.6 Million Dollars in 2024

An annual OIG analysis posted Wednesday found CMS applied price reductions to 14 physician-administered drugs based on 2024 market data, while reporting that errors in manufacturer price submissions blocked the review of 31 additional drugs.

September 24, 2026

Drug prices & Part D

CMS Must Send Final Written Price Offers to 15 Drug Makers by September 30 in Third Negotiation Cycle

The final statutory step before drug manufacturers accept or reject Medicare prices arrives this week. CMS must issue written maximum fair price offers by September 30, and manufacturers have until October 31 to respond. Agreed prices would take effect in 2028.

September 23, 2026

Drug prices & Part D

About 140,000 Wellcare Part D Members Were Dropped Mid-Year After Small New Premiums Were Added to Their Previously Free Plans

KFF Health News found that Wellcare terminated tens of thousands of drug plan members in April 2026 when minimal monthly premiums went unpaid, leaving many without prescription coverage and at risk for permanent Medicare drug enrollment penalties.

September 21, 2026